open access

Vol 10, No 1 (2007)
Published online: 2007-02-15
Submitted: 2012-01-23
Get Citation

Production and tumour uptake of [64Cu]Pyruvaldehyde-bis (N4-methylthiosemicarbazone) for PET and/or therapeutic purposes

Amir Reza Jalilian, Pejman Rowshanfarzad, Yousef Yari Kamrani, Kamaleddin Shafaii, Mohammad Mirzaii
Nucl. Med. Rev 2007;10(1):6-11.

open access

Vol 10, No 1 (2007)
Published online: 2007-02-15
Submitted: 2012-01-23

Abstract


BACKGROUND: Copper-64 (T1/2=12.7ºh) is an important radionuclide used both in PET imaging and therapy. [64Cu]-pyruvaldehyde- bis(N4-methylthiosemicarbazone) ([64Cu]-PTSM) has already been used in the detection of cerebral and myocardial blood flow. In this study, a simple production method and tumour accumulation of [64Cu]-PTSM in fibrosarcoma-bearing mice were reported.
MATERIAL AND METHODS: Cu-64 was produced via the 68Zn(p, αn)64Cu nuclear reaction. [64Cu]-PTSM was prepared using in-house made PTSM ligand and [64Cu]cuprous acetate and injected to fibrosarcoma-bearing mice.
RESULTS: Copper-64 was prepared in chloride form (≈ 200 mCi, > 95% chemical yield at 180º μA for 1.1 h irradiation, radionuclidic purity > 96%, copper-67 as impurity). The solution of 64Cu- PTSM was prepared in > 80% radiochemical yield and more than 98% radiochemical purity. A significant tumour uptake was observed 2 hours post injection in tumour-bearing mice (tu- mour/muscle: 9, tumour/blood: 6).
CONCLUSION: [64Cu]-PTSM was prepared on a radiopharmaceutical scale using readily available zinc-68, with high quality and was shown to possess application in the therapy and/or imaging of fibrosarcoma.

Abstract


BACKGROUND: Copper-64 (T1/2=12.7ºh) is an important radionuclide used both in PET imaging and therapy. [64Cu]-pyruvaldehyde- bis(N4-methylthiosemicarbazone) ([64Cu]-PTSM) has already been used in the detection of cerebral and myocardial blood flow. In this study, a simple production method and tumour accumulation of [64Cu]-PTSM in fibrosarcoma-bearing mice were reported.
MATERIAL AND METHODS: Cu-64 was produced via the 68Zn(p, αn)64Cu nuclear reaction. [64Cu]-PTSM was prepared using in-house made PTSM ligand and [64Cu]cuprous acetate and injected to fibrosarcoma-bearing mice.
RESULTS: Copper-64 was prepared in chloride form (≈ 200 mCi, > 95% chemical yield at 180º μA for 1.1 h irradiation, radionuclidic purity > 96%, copper-67 as impurity). The solution of 64Cu- PTSM was prepared in > 80% radiochemical yield and more than 98% radiochemical purity. A significant tumour uptake was observed 2 hours post injection in tumour-bearing mice (tu- mour/muscle: 9, tumour/blood: 6).
CONCLUSION: [64Cu]-PTSM was prepared on a radiopharmaceutical scale using readily available zinc-68, with high quality and was shown to possess application in the therapy and/or imaging of fibrosarcoma.
Get Citation

Keywords

Copper-64; PTSM; PET; targeted therapy; fibrosarcoma

About this article
Title

Production and tumour uptake of [64Cu]Pyruvaldehyde-bis (N4-methylthiosemicarbazone) for PET and/or therapeutic purposes

Journal

Nuclear Medicine Review

Issue

Vol 10, No 1 (2007)

Pages

6-11

Published online

2007-02-15

Bibliographic record

Nucl. Med. Rev 2007;10(1):6-11.

Keywords

Copper-64
PTSM
PET
targeted therapy
fibrosarcoma

Authors

Amir Reza Jalilian
Pejman Rowshanfarzad
Yousef Yari Kamrani
Kamaleddin Shafaii
Mohammad Mirzaii

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl